Debt-to-equity rose from 0.88 in 2025Q4 to 1.01 in 2026Q2, while cash declined from $135M to $123M, indicating increased reliance on debt as liquidity thins (current ratio 1.47).
Sylvamo Corp (SLVM) balance sheet — 7-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 |
|---|
| Total Current Assets | 1.38B | 1.08B | 1.06B | 1.19B | 1.24B | 1.11B | 1.12B | 1.39B |
| Cash & Short-Term Investments | 93M | 135M | 205M | 220M | 360M | 159M | 95M | 135M |
| Cash Only | 93M | 135M | 205M | 220M | 360M | 159M | 95M | 135M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 303M | 443M | 455M | 455M | 480M | 428M | 621M | 711M |
| Days Sales Outstanding | 44.51 | 48.25 | 44.02 | 44.63 | 48.29 | 55.24 | 95.04 | 64.6 |
| Inventory | 369M | 418M | 361M | 404M | 364M | 279M | 342M | 443M |
| Days Inventory Outstanding | 63.1 | 58.32 | 46.51 | 52.5 | 50.73 | 47.52 | 64.71 | 61.29 |
| Other Current Assets | 614M | 80M | 42M | 114M | 39M | 242M | 61M | 104M |
| Total Non-Current Assets | 1.57B | 1.69B | 1.54B | 1.68B | 1.47B | 1.49B | 1.79B | 2.08B |
| Property, Plant & Equipment | 982M | 1.46B | 1B | 1.06B | 852M | 804M | 1.31B | 1.58B |
| Fixed Asset Turnover | 2.60x | 2.30x | 3.77x | 3.51x | 4.26x | 3.52x | 1.82x | 2.53x |
| Goodwill | 121M | 114M | 111M | 139M | 128M | 122M | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 143M | 179M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 469M | 114M | 428M | 480M | 487M | 563M | 336M | 313M |
| Total Assets | 2.95B | 2.76B | 2.6B | 2.87B | 2.71B | 2.6B | 2.91B | 3.47B |
| Asset Turnover | 1.08x | 1.21x | 1.45x | 1.30x | 1.34x | 1.09x | 0.82x | 1.16x |
| Asset Growth % | 30.84% | 6.11% | -9.33% | 5.98% | 4.35% | -10.79% | -16.11% | - |
| Total Current Liabilities | 1.06B | 716M | 682M | 695M | 728M | 758M | 490M | 580M |
| Accounts Payable | 283M | 381M | 375M | 421M | 453M | 387M | 259M | 311M |
| Days Payables Outstanding | 53.13 | 53.16 | 48.31 | 54.7 | 63.13 | 65.91 | 49.01 | 43.03 |
| Short-Term Debt | 139M | 90M | 22M | 28M | 29M | 41M | 18M | 21M |
| Deferred Revenue (Current) | 2M | 0 | 0 | 0 | 0 | 0 | 11M | 0 |
| Other Current Liabilities | 592M | 190M | 206M | 183M | 165M | 282M | 134M | 174M |
| Current Ratio | 1.29x | 1.50x | 1.56x | 1.72x | 1.71x | 1.46x | 2.28x | 2.40x |
| Quick Ratio | 0.95x | 0.92x | 1.03x | 1.14x | 1.21x | 1.09x | 1.59x | 1.64x |
| Cash Conversion Cycle | 54.47 | 53.42 | 42.21 | 42.42 | 35.89 | 36.85 | 110.74 | 82.87 |
| Total Non-Current Liabilities | 1.15B | 1.08B | 1.07B | 1.28B | 1.3B | 1.66B | 309M | 373M |
| Long-Term Debt | 861M | 763M | 782M | 931M | 1B | 1.36B | 1M | 2M |
| Capital Lease Obligations | 53M | 0 | 0 | 0 | 0 | 0 | 53M | 51M |
| Deferred Tax Liabilities | 673M | 175M | 152M | 189M | 183M | 169M | 170M | 236M |
| Other Non-Current Liabilities | 137M | 143M | 141M | 156M | 118M | 131M | 85M | 84M |
| Total Liabilities | 2.21B | 1.8B | 1.76B | 1.97B | 2.03B | 2.42B | 799M | 953M |
| Total Debt | 1B | 853M | 804M | 959M | 1.03B | 1.4B | 72M | 74M |
| Net Debt | 907M | 718M | 599M | 739M | 672M | 1.24B | -23M | -61M |
| Debt / Equity | 1.35x | 0.88x | 0.95x | 1.06x | 1.52x | 7.68x | 0.03x | 0.03x |
| Debt / EBITDA | 2.92x | 1.99x | 1.33x | 1.76x | 1.61x | 3.09x | 0.32x | 0.11x |
| Net Debt / EBITDA | 2.64x | 1.68x | 0.99x | 1.35x | 1.05x | 2.74x | -0.10x | -0.09x |
| Interest Coverage | 4.00x | 5.42x | 8.64x | 7.15x | 7.00x | 11.58x | 24.75x | 126.50x |
| Total Equity | 740M | 966M | 847M | 901M | 678M | 182M | 2.11B | 2.52B |
| Equity Growth % | -2.81% | 14.05% | -5.99% | 32.89% | 272.53% | -91.38% | -16.09% | - |
| Book Value per Share | 18.50 | 23.56 | 20.17 | 21.10 | 15.27 | 4.14 | 47.88 | 57.07 |
| Total Shareholders' Equity | 740M | 966M | 847M | 901M | 678M | 182M | 2.11B | 2.52B |
| Common Stock | 46M | 46M | 45M | 45M | 44M | 44M | 0 | 0 |
| Retained Earnings | 2.25B | 2.51B | 2.46B | 2.22B | 2.03B | 1.94B | 0 | 0 |
| Treasury Stock | -336M | -330M | -234M | -158M | -82M | 0 | 0 | 0 |
| Accumulated OCI | -1.32B | -1.35B | -1.49B | -1.26B | -1.34B | -1.8B | 2.11B | 2.52B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying SLVM stock.
As of 2025, Sylvamo Corp (SLVM) had total assets of $2.76B including $1.08B in current assets.
Sylvamo Corp (SLVM) carries total debt of $853.0M, offset by $135.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Sylvamo Corp (SLVM) has total shareholders' equity (book value) of $966.0M ($23.56 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Sylvamo Corp (SLVM) reported a current ratio of 1.50x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Secular demand decline and negative operating leverage
Metrics are mathematically derived from official filings.
Balance Sheet Expansion Amid Revenue Contraction
Total assets grew from $2.6B in 2024Q4 to $2.9B in 2026Q2, while revenue declined 11.2% year-over-year, suggesting asset growth is not translating into sales growth, per the latest quarterly data.
The sequential increase in total assets, driven largely by a rise in PPE from $1.0B to $1.2B, appears inconsistent with the revenue trajectory, implying that capital expenditures are being maintained despite weak demand. This may indicate that management is investing for the long term, but it also raises the risk of asset impairment if the secular decline in paper demand accelerates. Investors should monitor whether this asset expansion eventually yields productivity gains or becomes a drag on returns.
Leverage Creeps Higher as Cash Reserves Thin
Debt-to-equity rose from 0.88 in 2025Q4 to 1.01 in 2026Q2, while cash fell from $135M to $123M, indicating increased reliance on debt to fund operations, as reported in the balance sheet.
Total debt increased by $111M over the last two quarters, while cash remained relatively flat, suggesting that the company is borrowing to cover capital expenditures and shareholder returns. The D/E ratio, though still moderate, is trending upward and may signal that the company is using leverage to bridge the gap between declining cash flows and its capital allocation commitments. If operating cash flow continues to weaken, this leverage could become more burdensome, especially if interest rates remain elevated.
Asset Base Shifts Toward Heavier Fixed Assets
Net PPE rose from $1.0B in 2024Q4 to $1.2B in 2026Q2, while goodwill remained stable around $121M, indicating a growing fixed-asset base, according to the latest balance sheet data.
The increase in PPE suggests that Sylvamo is investing in its mills, possibly to maintain efficiency or expand capacity, but this comes at a time when revenue is declining. The stable goodwill implies that no major acquisitions have occurred, and the risk of impairment appears low. However, the rising fixed-asset intensity could lead to higher depreciation charges, further pressuring margins if utilization rates do not improve.
Equity Growth Masks Underlying Earnings Strain
Equity increased from $847M in 2024Q4 to $955M in 2026Q2, but retained earnings remained flat at $2.5B, suggesting that equity growth is driven by other factors, per the balance sheet data.
The rise in equity, despite flat retained earnings, may be attributable to share issuance or other comprehensive income, but the lack of retained earnings growth indicates that the company is not generating sufficient net income to build equity organically. This is consistent with the recent net loss in 2026Q2 and suggests that the balance sheet strength is not being reinforced by profitability. Investors should watch whether equity growth can be sustained without earnings support.
Liquidity Buffer Thins as Current Ratio Declines
The current ratio fell from 1.72 in 2024Q3 to 1.47 in 2026Q2, while cash dropped from $248M to $123M, indicating a shrinking liquidity cushion, as reported in the balance sheet.
The declining current ratio and cash balance suggest that Sylvamo's ability to cover short-term obligations is weakening, though the ratio remains above 1.0, providing some buffer. The reduction in cash may be due to debt repayment, capital expenditures, or shareholder returns, but it also reduces the company's flexibility to absorb demand shocks. If the current ratio continues to decline, it could signal increased financial stress, especially if operating cash flow remains volatile.
Pension and Biological Asset Estimates May Distort Equity
Sylvamo's balance sheet includes pension and OPEB liabilities inherited from International Paper, as well as biological assets in Latin America, which are subject to significant estimation, per the company's disclosures.
The reported equity of $955M may be overstated if pension obligations are underfunded or if biological asset valuations are optimistic. Changes in discount rates or timber price assumptions could materially impact the balance sheet. Investors should scrutinize the assumptions underlying these estimates, as they could lead to future write-downs or increased liabilities, undermining the apparent health of the balance sheet.